Safety and efficacy of levodopa-carbidopa intestinal gel: results from an open-label extension study in Japanese, Korean and Taiwanese patients with advanced Parkinson’s disease

OBJECTIVES: Levodopa-carbidopa intestinal gel (LCIG) was developed to reduce motor complications in Parkinson’s disease (PD) caused by pulsatile levodopa plasma concentrations following oral levodopa administration. Dyskinesia and ‘wearing off’ symptoms can vary between Asian and Caucasian patients...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ther Adv Neurol Disord
Hlavní autoři: Murata, Miho, Mihara, Masahito, Hasegawa, Kazuko, Jeon, Beomseok, Tsai, Chon-Haw, Nishikawa, Noriko, Oeda, Tomoko, Yokoyama, Masayuki, Robieson, Weining Z., Chatamra, Krai, Facheris, Maurizio F., Benesh, Janet
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2018
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5833238/
https://ncbi.nlm.nih.gov/pubmed/29511383
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286418759315
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky